LifeMD (NASDAQ:LFMD – Get Free Report) is one of 233 publicly-traded companies in the “Healthcare Providers & Services” industry, but how does it contrast to its competitors? We will compare LifeMD to related companies based on the strength of its analyst recommendations, valuation, risk, profitability, dividends, institutional ownership and earnings.
Valuation and Earnings
This table compares LifeMD and its competitors revenue, earnings per share and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| LifeMD | $194.05 million | $14.35 million | -30.83 |
| LifeMD Competitors | $21.12 billion | $301.67 million | -1.62 |
LifeMD’s competitors have higher revenue and earnings than LifeMD. LifeMD is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
Profitability
| Net Margins | Return on Equity | Return on Assets | |
| LifeMD | -0.25% | -139.69% | -32.17% |
| LifeMD Competitors | -7.86% | -135.43% | -1.59% |
Analyst Recommendations
This is a breakdown of recent ratings and recommmendations for LifeMD and its competitors, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| LifeMD | 1 | 1 | 8 | 0 | 2.70 |
| LifeMD Competitors | 1880 | 7755 | 13395 | 833 | 2.55 |
LifeMD presently has a consensus price target of $7.14, indicating a potential upside of 286.10%. As a group, “Healthcare Providers & Services” companies have a potential upside of 12.73%. Given LifeMD’s stronger consensus rating and higher possible upside, equities analysts clearly believe LifeMD is more favorable than its competitors.
Volatility & Risk
LifeMD has a beta of 2.19, suggesting that its stock price is 119% more volatile than the S&P 500. Comparatively, LifeMD’s competitors have a beta of 0.98, suggesting that their average stock price is 2% less volatile than the S&P 500.
Insider & Institutional Ownership
35.5% of LifeMD shares are owned by institutional investors. Comparatively, 56.7% of shares of all “Healthcare Providers & Services” companies are owned by institutional investors. 17.2% of LifeMD shares are owned by insiders. Comparatively, 14.9% of shares of all “Healthcare Providers & Services” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Summary
LifeMD competitors beat LifeMD on 7 of the 13 factors compared.
About LifeMD
LifeMD, Inc. is a virtual healthcare company that connects patients with medical providers through its telehealth platform. Its services include virtual primary care and specialty care, with offerings in areas such as men’s health and weight management. The company operates the LifeMD and Rex MD brands and supports care through online consultations, treatment plans and, when prescribed, medication. Service availability and treatment options may vary by state and individual patient needs. LifeMD serves patients in the United States.
Receive News & Ratings for LifeMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeMD and related companies with MarketBeat.com's FREE daily email newsletter.
